NasdaqCM - Nasdaq Real Time Price USD

BioNexus Gene Lab Corp. (BGLC)

Compare
0.3512
+0.0052
+(1.50%)
As of 12:37:55 PM EST. Market Open.
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
11,399.7930
8,740.1620
9,574.3900
10,115.2930
Total Liabilities Net Minority Interest
1,741.9410
2,075.1490
2,394.6110
3,453.1390
Total Equity Gross Minority Interest
9,657.8520
6,665.0130
7,179.7790
6,662.1540
Total Capitalization
9,657.8520
6,665.0130
7,179.7790
6,662.1540
Common Stock Equity
9,657.8520
6,665.0130
7,179.7790
6,662.1540
Capital Lease Obligations
133.3950
56.7750
76.9470
123.4190
Net Tangible Assets
9,657.8520
6,665.0130
7,179.7790
6,662.1540
Working Capital
6,415.8770
4,017.7490
4,821.1000
4,611.8960
Invested Capital
9,657.8520
6,665.0130
7,179.7790
6,662.1540
Tangible Book Value
9,657.8520
6,665.0130
7,179.7790
6,662.1540
Total Debt
133.3950
56.7750
76.9470
123.4190
Share Issued
17,667.6630
14,476.5120
14,268.1790
14,268.1790
Ordinary Shares Number
17,667.6630
14,476.5120
14,268.1790
14,268.1790
12/31/2020 - 1/8/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers